External genital warts: Report of the American Medical Association Consensus Conference

Clinical Infectious Diseases

Volumn 27, Issue 4, 1998, Pages 796-806

  Beutner, Karl R ^a   Reitano, Michael V ^b   Richwald, Gary A ^b   Wiley, Dorothy J ^b  

^a Solano Dermatology Associates   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIVIRUS AGENT; DICHLOROACETIC ACID; FLUOROURACIL; IMIQUIMOD; INTERFERON; PODOPHYLLIN; PODOPHYLLOTOXIN; TRICHLOROACETIC ACID;

ARTICLE; CONDYLOMA; CRYOTHERAPY; ELECTROSURGERY; EXCISION; HUMAN; LASER SURGERY; PATIENT COUNSELING; POPULATION RISK; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEXUAL ABUSE; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; UTERINE CERVIX DISEASE;

EID: 2442769273     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514964     Document Type: Article

References (113)

1. Institute of Medicine Committee on Prevention and Control of Sexually Transmitted Diseases. The hidden epidemic: confronting sexually transmitted diseases. Washington, DC: National Academy Press, 1997.
2. U.S. Centers for Disease Control, Division of STD Prevention. Sexually transmitted disease surveillance 1995. Atlanta: Centers for Disease Control and Prevention, U.S. Department of Health Services, Public Health Service, 1996.
3. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988; 10:122-63.
4. de Villiers EM. Human pathogenic papillomavirus types. An update. Curr Top Microbiol Immunol 1994; 186:1-12.
5. Delius H, Hofmann B. Primer-directed sequencing of human papillomavirus types. Curr Top Microbiol Immunol 1994; 186:13-31.
6. Durst M, Gissmann L, Ikenberg H, et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983; 80: 3812-5.
7. Gissmann L, zur Hausen H. Partial characterization of viral DNA from human genital warts (condylomata acuminata). Int J Cancer 1980; 25: 605-9.
8. Gissmann L, deVilliers EM, zur Hausen H. Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA. Int J Cancer 1982; 29:143-6.
9. Gissmann L. Human papillomavirus DNA in genital tumours. IARC Sci Publ 1984; 63:405-11.
10. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327:1272-8.
11. Lorincz AT, Reid R, Jenson AB, et al. Human papillomavirus infection of the cervix. Relative risk associations of 15 common anogenital types. Obstet Gynecol 1992; 79:328-37.
12. Gissmann L, Boshart M, Durst M, et al. Presence of human papillomavirus in genital rumors. J Invest Dermatol 1984; 83:26s-8s.
13. Fuchs PG, Girardi F, Pfister H. Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients, a diagnostic marker for early metastases? Int J Cancer 1989; 43:41-4.
14. Fuchs PG, Girardi F, Pfister H. Human papillomavirus DNA in normal, metaplastic, preneoplastic and neoplastic epithelia of the cervix uteri. Int J Cancer 1988; 41:41-5.
15. Kadish AS, Hagan RJ, Ritter DB, et al. Biologic characteristics of specific human papillomavirus types predicted from morphology of cervical lesions. Hum Pathol 1992; 23:1262-9.
16. Boshart M, Gissmann L, Ikenberg H, et al. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984; 3:1151-7.
17. Beckmann AM, Daling JR, Sherman KJ, et al. Human papillomavirus infection and anal cancer. Int J Cancer 1989; 43:1042-9.
18. Palefsky JM, Gonzales J, Greenblatt RM, et al. Anal intraepithelial neoplasia and anal papillomavirus infection among homosexual males with group IV HIV disease. JAMA 1990; 263:2911-6.
19. Zaki SR, Judd R, Coffield LM, et al. Human papillomavirus infection and anal carcinoma. Retrospective analysis by in situ hybridization and the polymerase chain reaction. Am J Pathol 1992; 140:1345-55.
20. Gissmann L, Diehl V, Schultz-Coulon HJ, et al. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol 1982; 44:393-400.
21. Gissmann L, Wolnik L, Ikenberg H, et al. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA 1983; 80:560-3.
22. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991; 265:472-7.
23. Bauer HM, Hildesheim A, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993; 20:274-8.
24. Ley C, Bauer HM, Reingold A, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991; 83:997.
25. Melkert PW, Hopman E, van den Brule AJ, et al. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993; 53: 919-23.
26. U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore: Williams & Wilkins, 1996.
27. Schultz RE, Miller JW, MacDonald GR, et al. Clinical and molecular evaluation of acetowhite genital lesions in men. J Urol 1990; 143: 920-3.
28. Wikstrom A, Hedblad MA, Johansson B, et al. The acetic acid test in evaluation of subclinical genital papillomavirus infection. A comparative study on penoscopy, histopathology, virology and scanning electron microscopy findings. Genitourinary Medicine 1992; 68:90-9.
29. Condylomata International Collaborative Study Group. Randomized, placebo-controlled, double-blind combined therapy with laser surgery and systemic interferon-α 2a in the treatment of anogenital condylomata acuminatum. J Infec Dis 1993; 167:824-9.
30. Armstrong DK, Maw RD, Dinsmore WW, et al. Combined therapy trial with interferon alpha-2a and ablative therapy in the treatment of anogenital warts. Genitourinary Medicine 1996; 72:103-7.
31. Rader JS, Leake JF, Dillon MB, et al. Ultrasonic surgical aspiration in the treatment of vulvar disease. Obstet Gynecol 1991; 77:573-6.
32. Moscicki AB. Genital HPV infections in children and adolescents. Obstet Gynecol Clin North Am 1996; 23:675-97.
33. Ferenczy A, Mitao M, Nagai N, et al. Latent papillomavirus and recurring genital warts. N Engl J Med 1985; 313:784-8.
34. Beutner K, Wiley D. Recurrent external genital warts: a literature review. Papillomavirus Report 1997; 8:69-74.
35. Baggish MS. Improved laser techniques for the elimination of genital and extragenital warts. Am J Obstet Gynecol 1985; 153:545-50.
36. von Krogh G, Wikstrom A. Efficacy of chemical and/or surgical therapy against condylomata acuminata. A retrospective evaluation. Int J STD AIDS 1991; 2:333-8.
37. Friedman-Kien A. Management of condylomata acuminata with Alferon N injection, interferon alfa-n3 (human leukocyte derived). Am J Obstet Gynecol 1995; 172:1359-68.
38. Friedman-Kien AE, Eron LJ, Conant M, et al. Natural interferon alfa for treatment of condylomata acuminata. JAMA 1988; 259:533-8.
39. Rotola A, Costa S, Monini P, et al. Impact of sexual habits on the clinical evaluation of male HPV infection. Eur J Epidemiol 1994; 10:373-80.
40. Barrett TJ, Silbar JD, McGinley JP. Genital warts - a venereal disease. JAMA 1954; 154:333-4.
41. Sherman KJ, Daling JR, Chu J. et al. Multiple primary tumours in women with vulvar neoplasms. A case-control study. Br J Cancer 1988; 57: 423-7.
42. Bergman A, Nalick R. Prevalence of human papillomavirus infection in men. Comparison of the partners of infected and uninfected women. J Reprod Med 1992; 37:710-2.
43. O'Hanlan K, Crum CP. Human papillomavirus-associated cervical intra-epithelial neoplasia following lesbian sex. Obstet Gynecol 1996; 88: 702-3.
44. Hawkes AP, Kronenberger CB, MacKenzie TD, et al. Cervical cancer screening. American College of Preventive Medicine practice policy statement. Am J Prev Med 1996; 12:342-4.
45. Planner RS, Hobbs JB. Human papilloma virus infection and associated intraepithelial neoplasia of the cervix, vagina and vulva. Aust NZ J Obstet Gynaecol 1987; 27:132-5.
46. Walker PG, Colley NV, Grubb C, et al. Abnormalities of the uterine cervix in women with vulval warts. A preliminary communication. British Journal of Venereal Diseases 1983; 59:120-3.
47. Bergeron C, Ferenczy A, Shah KV, et al. Multicentric human papillomavirus infections of the female genital tract. Correlation of viral types with abnormal mitotic figures, colposcopic presentation, and location. Obstet Gynecol 1987; 69:736-42.
48. Rabkin CS, Yellin F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst 1994; 86:1711-6.
49. Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987; 317:973-7.
50. Melbye M, Cote TR, Kessler L, et al. High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet 1994; 343:636-9.
51. Palefsky JM, Holly EA, Hogeboom CJ, et al. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:415-22.
52. Beutner KR, Conant MA, Friedman-Kien AE, et al. Patient-applied podofilox for treatment of genital warts. Lancet 1989; 1:831-4.
53. Gutman LT, Herman-Giddens ME, Phelps WC. Transmission of human genital papillomavirus disease. Comparison of data from adults and children. Pediatrics 1993; 91:31-8.
54. Law CL, Thompson CH, Rose BR, et al. Anal intercourse: a risk factor for anal papillomavirus infection hi women? Genitourinary Medicine 1991; 67:464-8.
55. Oriel JD. Sexually transmitted diseases in children: human papillomavirus infection. Genitourinary Medicine 1992; 68:80-3.
56. Ingram DL, Everett VD, Lyna PR, et al. Epidemiology of adult sexually transmitted disease agents in children being evaluated for sexual abuse. Pediatr Infect Dis J 1992; 11:945-50.
57. American Professional Society on the Abuse of Children. Guidelines for psychosocial evaluation of suspected sexual abuse of young children. Chicago: American Professional Society on the Abuse of Children, 1991:1-7.
58. American Academy of Pediatrics, Committee on Abuse and Neglect. Guidelines for evaluation of sexual abuse of children. Pediatrics 1991; 87:254-9.
59. Bonnez W, Oakes D, Bailey-Farchione A, et al. A randomized, double-blind, placebo-controlled trial of systemically administered interferon-α, -β, or -γ in combination with cryotherapy for the treatment of condyloma acuminatum. J Infec Dis 1995; 171:1081-9.
60. Bellina JH. The use of the carbon dioxide laser in the management of condyloma acuminatum with eight-year follow-up. Am J Obstet Gynecol 1983; 147:375-8.
61. Ferenczy A. Laser therapy of genital condylomata acuminata. Obstet Gynecol 1984; 63:703-7.
62. Syed TA, Khayyami M, Kriz D, et al. Management of genital warts in women with human leukocyte interferon-alpha vs. podophyllotoxin in cream: a placebo-controlled, double-blind, comparative study. J Mol Med 1995; 73:255-8.
63. von Krogh G, Szpak E, Andersson M, et al. Self-treatment using 0.25%-0.50% podophyllotoxin-ethanol solutions against penile condylomata acuminata. A placebo-controlled comparative study. Genitourinary Medicine 1994; 70:105-9.
64. Kirby PK, Kiviat N, Beckman A, et al. Tolerance and efficacy of recombinant human interferon gamma in the treatment of refractory genital warts. Am J Med 1988; 85:183-8.
65. Greenberg MD, Rutledge LH, Reid R, et al. A double-blind, randomized trial of 0.5% podofilox and placebo for the treatment of genital warts in women. Obstet Gynecol 1991; 77:735-9.
66. Jensen SL. Comparison of podophyllin application with simple surgical excision in clearance and recurrence of perianal condylomata acuminata. Lancet 1985; 2:1146-8.
67. Schoenfeld A, Ziv E, Levavi H, et al. Laser versus loop electrosurgical excision in vulvar condyloma for eradication of subclinical reservoir demonstrated by assay for 2′5′ oligosynthetase human papillomavirus. Gynecol Obstet Invest 1995; 40:46-51.
68. Armstrong DK, Maw RD, Dinsmore WW, et al. A randomised, double-blind, parallel group study to compare subcutaneous interferon alpha-2a plus podophyllin with placebo plus podophyllin in the treatment of primary condylomata acuminata. Genitourinary Medicine 1994; 70: 389-93.
69. Bar-Am A, Shilon M, Peyser MR, et al. Treatment of male genital condylomatous lesions by carbon dioxide laser after failure of previous non-laser methods. J Am Acad Dermatol 1991; 24:87-9.
70. Bashi SA. Cryotherapy versus podophyllin in the treatment of genital warts. Int J Dermatol 1985; 24:535-6.
71. Wikstrom A. Clinical and serological manifestations of genital human papillomavirus infection. Acta Derm Venereol Suppl (Stockh) 1995; 193:1-85.
72. Rowson KE, Mahy BW. Human papova (wart) virus. Bacteriological Reviews 1967; 31:110-31.
73. Happonen HP, Lassus A, Santalahti J, et al. Topical idoxuridine for treatment of genital warts in males. A double-blind comparative study of 0.25% and 0.5% cream. Genitourinary Medicine 1990; 66:254-6.
74. Condylomata International Collaborative Study Group. A comparison of interferon alfa-2a and podophyllin in the treatment of primary condylomata acuminata. Genitourinary Medicine 1991; 67:394-9.
75. Meisels A, Fortin R. Condylomatous lesions of the cervix and vagina. I. Cytologic patterns. Acta Cytol 1976; 20:505-9.
76. Meisels A, Fortin R, Roy M. Condylomatous lesions of the cervix. II. Cytologic, colposcopic and histopathologic study. Acta Cytol 1977; 21:379-90.
77. Fitzpatrick J, Gentry RH. Nonvenereal diseases of male genitalia. In: Moschella SL, Hurley HJ, eds. Dermatology: Philadelphia: WB Saunders, 1992:1013-4.
78. Gonzalez E. Molluscum contagiosum and other viruses. In: Moschella SL, Hurley HJ, eds. Dermatology. Philadelphia: WB Saunders, 1992: 1014-5.
79. Jakubovic H, Ackerman AB. Structure and function of skin: development, morphology, and physiology. In: Moschella SL, Hurley HJ, eds. Dermatology. Philadelphia: WB Saunders, 1992:64.
80. Gibson L, Perry HO. Papulosquamous eruptions and exfoliative dermatitis. In: Moschella SL, Hurley HJ, eds. Dermatology. Philadelphia: WB Saunders, 1992:629-36.
81. Oriel JD. Sexually transmitted diseases in children: human papillomavirus infection. Genitourinary Medicine 1991; 67:394-9.
82. Koh H, Ghawan J. Tumors of the skin. In: Moschella SL, Hurley HJ, eds. Dermatology. Philadelphia: WB Saunders, 1992:1721-808.
83. Wade TR, Kopf AW, Ackerman AB. Bowenoid papulosis of the penis. Cancer 1978; 42:1890-903.
84. Wade TR, Kopf AW, Ackerman AB. Bowenoid papulosis of the genitalia. Arch Dermatol 1979; 115:306-8.
85. Webster S. Nontreponemal sexually transmissible diseases. In: Moschella SL, Hurley HJ, eds. Dermatology. Philadelphia: WB Saunders, 1992: 987-1007.
86. Patterson JW, Kao GF, Graham JH, et al. Bowenoid papulosis. A clinicopathologic study with ultrastructural observations. Cancer 1986; 57: 823-36.
87. Ikenberg H, Gissmann L, Gross G, et al. Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid papulosis. Int J Cancer 1983; 32:563-5.
88. Broker TR. Structure and genetic expression of papillomaviruses. Obstet Gynecol Clin North Am 1987; 14:329-48.
89. Buschke A, Lowenstein L. Uber carcinomahnliche condylomata acuminata. Klin Wochenschr 1925;4:1726.
90. Buck HW, Peterson CM, Cox JT. HPV disease: diagnosis, management and prevention. Baltimore: American College Health Association, 1995.
91. IARC, Working Group on Evaluation of Carcinogenic Risks to Humans. IARC monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses. Lyon, France: World Health Organization, International Agency for Research on Cancer, 1995.
92. Eron LJ, Judson F, Tucker S, et al. Interferon therapy for condylomata acuminata. N Engl J Med 1986; 315:1059-64.
93. Condylomata International Collaborative Study Group. Recurrent condylomata acuminata treated with recombinant interferon alfa-2a. A multicenter double-blind placebo-controlled clinical trial. JAMA 1991; 265:2684-7.
94. Monsonego J, Cessot G, Ince SE, et al. Randomised double-blind trial of recombinant interferon-beta for condyloma acuminatum. Genitourinary Medicine 1996; 72:111-4.
95. Reid R. Physical and surgical principles governing carbon dioxide laser surgery on the skin. Dermatol Clin 1991; 9:297-316.
96. Reid R. Physical and surgical principles of laser surgery in the lower genital tract. Obstet Gynecol Clin North Am 1991; 18:429-74.
97. Kinghorn GR, McMillan A, Mulcahy F, et al. An open, comparative study of the efficacy of 0.5% podophyllotoxin lotion and 25% podophyllotoxin solution in the treatment of condylomata acuminata in males and females. Int J STD AIDS 1993; 4:194-9.
98. Wade TR, Ackerman AB. The effects of resin of podophyllin on condyloma acuminatum. Am J Dermatopathol 1984; 6:109-22.
99. Beutner KR, Spruance SL, Hougham AJ, et al. Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol 1998; 38:230-9.
100. Edwards L, Ferenczy A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV study group. Human papilloma virus. Arch Dermatol 1998; 134:25-30.
101. Petersen CS, Weismann K. Quercetin and kaempherol: an argument against the use of podophyllin? Genitourinary Medicine 1995; 71: 92-3.
102. Douglas JM Jr, Eron LJ, Judson FN, et al. A randomized trial of combination therapy with intralesional interferon alpha 2b and podophyllin versus podophyllin alone for the therapy of anogenital warts. J Infec Dis 1990; 162:52-9.
103. Edwards A, Atma-Ram A, Thin RN. Podophyllotoxin 0.5% v podophyllin 20% to treat penile warts. Genitourinary Medicine 1988; 64:263-5.
104. Gabriel G, Thin RN. Treatment of anogenital warts. Comparison of trichloracetic acid and podophyllin versus podophyllin alone. British Journal of Venereal Diseases 1983; 59:124-6.
105. Hellberg D, Svarrer T, Nilsson S, et al. Self-treatment of female external genital warts with 0.5% podophyllotoxin cream (Condyline) vs weekly applications of 20% podophyllin solution. Int J STD AIDS 1995; 6: 257-61.
106. Swinehart JM, Sperling M, Phillips S, et al. Intralesional fluorouracil/ epinephrine injectable gel for treatment of condylomata acuminata. A phase 3 clinical study. Arch Dermatol 1997; 133:67-73.
107. Swinehart J, Skinner R, McCarty J, et al. Management of condylomata acuminata. Two phase II clinical studies to evaluate intralesional therapy with fluorouracil/adrenaline injectable gel. Genitourinary Medicine 1997; 73:481-7.
108. Centers for Disease Control and Prevention. 1998 Guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998; 47(RR-1):88-98.
109. Duus BR, Philipsen T, Christensen JD, et al. Refractory condylomata acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treatment. Genitourinary Medicine 1985; 61: 59-61.
110. Reid R. The management of genital condylomas, intraepithelial neoplasia, and vulvodynia. Obstet Gynecol Clin North Am 1996; 23:917-91.
111. Hippelainen M, Yliskoski M, Saarikoski S, et al. Genital human papillomavirus lesions of the male sexual partners. The diagnostic accuracy of peniscopy. Genitourinary Medicine 1991; 67:291-6.
112. Hymel KP, Jenny C. Child sexual abuse. Pediatr Rev 1996; 17:236-49.
113. Clarke P, Ebel C, Catotti DN, et al. The psychosocial impact of human papillomavirus infection: implications for health care providers. Int J STD AIDS 1996; 7:197-200.